Firm initiates Class II recall (may cause temporary adverse health consequences) for Foam Burst Moisturizing Body Wash because of its "potential for ocular injuries from inadvertent spraying of Foam Burst Wash into the eyes," according to FDA Recalls and Court Actions report May 24. The recall, initiated by e-mail April 27, letter April 28 and press release May 4, involves 1.5 mil. canisters of the body wash. The recall is ongoing
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Market growth and product innovations are continuing as FDA looks to Congress for authorization to establish regulatory pathway agency says it needs to determine whether to allow hemp-derived ingredients in food, dietary supplements and non-drug topicals including cosmetics.
Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.
Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.
